海西新药(02637.HK)委任林慧怡为联席公司秘书、授权代表及法律程序代理人
HAIXI PHARMAHAIXI PHARMA(HK:02637) Ge Long Hui·2025-11-21 08:44

Core Points - Hai Xi New Drug (02637.HK) announced the resignation of Chen Xiaolin as co-secretary of the company and various authorized representative roles effective from November 21, 2025 [1] - Lin Huiyi has been appointed as co-secretary, authorized representative, and legal process agent, also effective from November 21, 2025 [1] - Lin Huiyi will share the company secretary responsibilities with the current co-secretary Zhang Junhuan [1]